These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 12167135

  • 1. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
    Saper JR, Lake AE, Cantrell DT, Winner PK, White JR.
    Headache; 2002 Jun; 42(6):470-82. PubMed ID: 12167135
    [Abstract] [Full Text] [Related]

  • 2. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.
    Saper JR, Winner PK, Lake AE.
    Headache; 2001 Apr; 41(4):357-68. PubMed ID: 11318882
    [Abstract] [Full Text] [Related]

  • 3. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 4. Modified-release formulation of tizanidine in chronic tension-type headache.
    Murros K, Kataja M, Hedman C, Havanka H, Säkö E, Färkkilä M, Peltola J, Keränen T.
    Headache; 2000 Sep; 40(8):633-7. PubMed ID: 10971659
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 8. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V, Auriel E, Karni A.
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [Abstract] [Full Text] [Related]

  • 9. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
    Fogelholm R, Murros K.
    Headache; 1992 Nov; 32(10):509-13. PubMed ID: 1468911
    [Abstract] [Full Text] [Related]

  • 10. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group.
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [Abstract] [Full Text] [Related]

  • 11. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [Abstract] [Full Text] [Related]

  • 12. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 13. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG.
    CNS Drugs; 2003 Jul; 17(6):373-81. PubMed ID: 12696998
    [Abstract] [Full Text] [Related]

  • 14. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study.
    Spira PJ, Beran RG, Australian Gabapentin Chronic Daily Headache Group.
    Neurology; 2003 Dec 23; 61(12):1753-9. PubMed ID: 14694042
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 23; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 16. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Jun 23; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 17. Tizanidine is not a cure for chronic daily headache.
    Warner JS.
    Headache; 2003 Mar 23; 43(3):296; author reply 296-7. PubMed ID: 12603653
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 23; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.